Current Headlines

  1. Sonoco ThermoSafe Survey Reveals Future Needs, Trends Of Cold Chain Industry
    10/20/2014

    Sonoco ThermoSafe, a unit of Sonoco and a leading global provider of temperature assurance packaging, revealed the results of its survey entitled “Assessing the Future of the Cold Chain Industry” at the 12th annual Cold Chain Global Forum in Boston on Oct. 9, 2014.

  2. Sanofi Ally Shantha Begins Rotavirus Vaccine Phase 3 Trial
    10/17/2014

    Sanofi’s vaccine division, Sanofi Pasteur, reported that its affiliate Shantha Biotechnics has initiated the Phase 3 clinical trial in India for its investigational vaccine for rotavirus.

  3. Pfenex, PATH Link Arms For Vaccine Development Model
    10/17/2014

    Clinical stage biotech Pfenex announced that it has partnered with international nonprofit organization PATH in a multi-product research initiative to improve vaccine production.

  4. Auspherix, Domainex Join Forces Against Drug-Resistant Infections
    10/17/2014

    Early-stage anti-infectives firm Auspherix and U.K.-based drug discovery services firm Domainex announced a new collaboration to develop treatments that will combat antibiotic-resistant bacterial infections.

  5. Rich Pharmaceuticals Acquires Phorbol Esters For Hodgkin's Lymphoma
    10/17/2014

    Rich Pharmaceuticals has acquired the patents, intellectual property, and commercialization rights for phorbol esters in the treatment of Hodgkin's lymphoma.

  6. Nuvilex Files For Orphan Status For Cell-In-A-Box Therapy
    10/16/2014

    Clinical stage biotech firm Nuvilex announced that it has submitted an application seeking Orphan Drug Designation for its Cell-in-a-Box treatment for pancreatic cancer.

  7. GAPVAC Vaccine For Glioblastoma Advances To Clinical Trial
    10/16/2014

    immatics biotechnologies and its partner BioNTech AG reported that they are advancing the Glioma Actively Personalized VAccine Consortium (GAPVAC) into a Phase 1/2 clinical trial to investigate the concept of fully personalized therapeutic vaccines against cancer.

  8. FDA Accepts Pfizer’s NDA For Breast Cancer Drug
    10/16/2014

    Pfizer announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for its breast cancer drug palbociclib. The company is seeking approval for palbociclib in combination with letrozole as a first-line treatment for patients with advanced breast cancer.

  9. New Vaccines Targeting Adults Could Help Eradicate Tuberculosis
    10/15/2014

    A new study indicates that vaccines targeting teens and adults can help eliminate tuberculosis (TB) more effectively than the present TB vaccine for infants, according to a recent report in the University Herald.

  10. DelMar’s Cancer Drug Promising For Treating Chemo-Resistant Lung Cancer
    10/15/2014

    DelMar Pharmaceuticals has announced promising new clinical data from its lead cancer drug, VAL-083, demonstrating the effectiveness of this compound in the treatment of non-small cell lung cancer (NSCLC).

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.